Leafix Medical · raw details

Transcatheter Solution to Functional Mitral Regurgitation · Givat Brenner · Founded 2025

active Seed ← back to profile

Highlights

IIA supported (ever)

About

Transcatheter Solution to Functional Mitral Regurgitation

LeaFix developed the only Transcatheter Functional Mitral valve Regurgitation repair solution, performed by an augmentation of the anterior leaflet. The system is composed of an implant and a delivery system, used for implantation of an implant into the anterior leaflet while expanding the implant within the leaflet, hence enlarging the leaflet area and creating coaptation of the leaflets.

Identity

NameLeafix Medical
Slugleafix-medical
Type / kindstartup
Source _idUbDN2032J4N7ixtJiCefgN66kSwR2tf1K6muNY1ROwVKw7oEYt0fkm

Status

Statusactive
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtCenter District
HQ cityGivat Brenner
HQ addressGivat Brenner, Israel

Web & social

Websitehttps://www.leafix-medical.com
LinkedInhttps://www.linkedin.com/company/107011627/

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
cardiovascularcatheterscardiology

Funding

Total raised$6.5M
Current stageSeed

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}